GAO
GAO Report Highlights Testing Data Challenges During COVID-19 Pandemic
Recent guidance from HHS has improved data collection by clarifying which testing data all laboratories must report, including demographic data.
Government Agency Defends Analysis of PAMA Implementation, Future Impact on Medicare Spending
Premium
The agency said its aim is to analyze the way CMS has chosen to implement PAMA and to estimate the potential financial impact to Medicare as a result of those choices.
Grassley Asks CMS to Explain Potential Unnecessary Spending on Lab Tests
After a GAO report found that CMS may be overpaying for lab tests, the legislator is asking the government payor to explain how it will ensure appropriate use of taxpayer funds.
Lab Group Disputes GAO Report Suggesting PAMA Rates May Lead to Billions in Excess Medicare Payments
ACLA was critical of the report, saying it "fails to reflect market reality" and calling on Congress to intervene to prevent further cuts.
In Wake of 'Flawed' GAO Report, Consumer Genomics Firms Call for Regulatory Plan for DTC Industry
Premium
A week after being hit with a GAO report that called test results from consumer genetics firms "misleading," the big three DTC companies criticized the agency for using "unscientific" methods in its undercover investigation, but welcomed greater regulatory oversight.